264 articles
Hong Tang, Chief Medical Officer at OnQuality Pharmaceuticals, a clinical stage pharma company pioneering the discovery and development of targeted canc...
Daniel Catenacci, MD, director of the Gastrointestinal Oncology Program at the University of Chicago, discusses data from Astellas’ Phase 2 FAST study...
While the numbers are constantly rising, more than 1 in 10 Americans – or more than 34 million people – live with diabetes already today. For many...
Dr. Clare Grace, Chief Patient Officer at Parexel, a leading Clinical Research Organization (CRO) discusses a report titled “Discussions on Diversity” that includes key takeaways...
Richard Marsden, CEO of Synairgen plc discusses full results from its SGO16 Phase II trial of its inhaled interferon beta formulation (SNG001) for the t...
Noam Emanuel, Co-Founder and CSO of PolyPid, a late-stage biopharma company aiming to improve surgical outcomes, discusses the second most prevalent typ...
Jeffrey Stark, MD, Head of Medical Immunology at UCB discusses the results from the BE RADIANT and BE SURE studies, comparing the efficacy and safety of...
Opioid use and dependency increased during the pandemic. Learn more on Health Professional Radio.
Scott Schliebner, SVP and Head of the Center for Rare Diseases at PRA Health Sciences, a global healthcare intelligence partner, discusses the launch of...
announced (March 2021) that the first patient has been dosed in the Phase 1 multi-center clinical trial for CT-0508, studying the potential of chimeric ...